Haw Par Corporation Limited (SGX:H02)

Market Cap	3.81B +34.8%
Revenue (ttm)	229.97M -6.1%
Net Income	265.46M +16.3%
EPS	1.20 +16.3%
Shares Out	221.37M
PE Ratio	14.35
Forward PE	13.80
Dividend	0.40 (2.33%)
Ex-Dividend Date	May 5, 2026

Volume	222,200
Average Volume	300,115
Open	17.19
Previous Close	17.16
Day's Range	17.06 - 17.32
52-Week Range	11.30 - 18.27
Beta	0.18
RSI	51.31
Earnings Date	May 11, 2026

About Haw Par Corporation

Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, The Association of Southeast Asian Nations countries, other Asian countries, and internationally. It manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands; and invests in quoted securities. The company also owns and leases various investment properties. In addition, it provides family and tourist oriented leisure activities primarily in the form of oceanariums. Further, ...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1969
• Employees: 595
• Stock Exchange: Singapore Exchange
• Ticker Symbol: H02

Financial Performance

In 2025, Haw Par Corporation's revenue was 229.97 million, a decrease of -6.07% compared to the previous year's 244.82 million. Earnings were 265.46 million, an increase of 16.29%.